Your browser doesn't support javascript.
loading
Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China.
Liu, Xiaoyu; Zhang, Peng; Li, Chao; Song, Xiang; Liu, Zhaoyun; Shao, Wenna; Li, Sumei; Wang, Xinzhao; Yu, Zhiyong.
Afiliação
  • Liu X; First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Zhang P; Department of General Surgery, Zouping People's Hospital, Binzhou, China.
  • Li C; Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Song X; First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Liu Z; Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Shao W; Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Li S; First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Wang X; College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Yu Z; Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Front Oncol ; 13: 1136380, 2023.
Article em En | MEDLINE | ID: mdl-37404769
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China